Opioid-related Emergency Department Visits and Hospitalizations Among Commercially Insured Individuals, 2009-2015

Kay, Cynthia; Bernstein, Joanne Scheff; Fergestrom, Nicole; Jackson, Jeffrey L.

doi:10.1097/ajp.0000000000000643

Cited by 8 publications

(8 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 37 Finally, another study performed on a US cohort of adults prescribed opioids chronically reported a rate of 73 ED visits per 100 000 in 2015. 38 Our results and those from other European researchers suggest that European countries should more systematically monitor opioid consumption and patterns of opioid‐related morbidities to prevent similar epidemics such as the one observed in the US. 10 , 13 , 39 , 40…”

Section: Discussionsupporting

confidence: 71%

See 1 more Smart Citation

Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital

Lorenzini

Wainstein

Spechbach

et al. 2022

Pharmacology Res & Perspec

View full text Add to dashboard Cite

Opioid use and associated morbidity and mortality have increased in several countries during the past 20 years. We performed a study whose objective was to assess the frequency and causes of opioid‐related emergency division (ED) visits in an adult tertiary Swiss University Hospital over 9 weeks in 2018. We primarily assessed opioid‐related adverse drug reactions (ADR), secondary overdose, misuse, abuse, and insufficient pain relief. Current opioid use was identified in 1037 (8.3%) of the 12 470 included ED visits. In 64 opioid users, an ADR was identified as a contributing cause of the ED visit, representing 6.2% of opioid users, and 0.5% of the total ED visits. Moreover, we identified an overdose in 16 opioid users, misuse or abuse in 19 opioid users, and compatible withdrawal symptoms in 7 opioid users. After pooling all these events, we conclude that the ED visits could be related to opioid use in 10.2% of opioid users. Finally, in 201 opioid users, insufficient pain relief (pain not responding to the current pharmacological treatment) was identified as a contributing cause of ED visits. In these cases, other factors than simply pharmacological nonresponse may have been involved. In the context of an ever‐increasing opioid use to better control chronic pain situations, these results should reinforce emergency network epidemiological surveillance studies at a national level.

show abstract

Section: Discussionsupporting

confidence: 71%

“…For example, a large US cohort study showed that in approximately two‐thirds of patients who visited the ED because of opioid use, a benzodiazepine was also prescribed. 38 The benefit/risk ratio of such drug associations should be assessed regularly.…”

Section: Discussionmentioning

confidence: 99%

Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital

Lorenzini

Wainstein

Spechbach

et al. 2022

Pharmacology Res & Perspec

View full text Add to dashboard Cite

show abstract

“…Because of the COVID-19 pandemic, this is expected to only get worse and may in fact affect financial viability of healthcare organizations, especially those serving rural communities and are already struggling to keep their doors open ( American Hospital Association, 2020 ). For example, since 2010, there were 129 rural hospitals that closed mostly because of financial problems as the hospitals were not profitable ( Sheps Center for Health Services Research, 2020 ); the southern states, which include Alabama, have the highest rates of opioid-related emergency room visits as well as opioid-related hospitalizations ( Kay et al, 2018 ). With rising unemployment, this is expected to get worse, further crippling the finical viability of struggling hospitals, and the consequences are vast.…”

Section: Impact Of Unemployment On Oud Treatment Trajectorymentioning

confidence: 99%

Effects of Unemployment on Opioid Use Treatment Trajectories

Mumba¹,

Davis²,

Smith³

et al. 2022

UJAN

View full text Add to dashboard Cite

Living with an opioid use disorder (OUD) can make finding and sustaining employment a significant challenge and is only expected to get worse in the COVID-19 environment. For most individuals in OUD treatment, being employed is an important part of their recovery journey. Employment has several benefits, including reductions in preoccupation with symptoms, social isolation, risk of suicide, hopelessness, and economic instability, which if not addressed often result in homelessness. Therefore, employment is an important social determinant of health, especially among those with OUD. Employment success and OUD, however, may vary based on race, age, gender, and socioeconomic status. Return to work support as states begin to reopen will be critically important to improve treatment outcomes for individuals with OUD in a post-COVID-19 environment, requiring utilizations of evidence-based interventions. Nurses, particularly psychiatric mental health and addiction nurses, should routinely screen for employment needs of their patients with OUD and connect them to the necessary support services. Finally, nurses should advocate for regulatory reform that allows for employment support services to be billable and integrated in psychiatric and behavioral health services just like other mental health services.

show abstract

“…1 – 5 Nationally representative data from the National Hospital Ambulatory Medical Care Survey shows that the ED visit rate for opioid overdose increased fourfold from 1993 to 2010. 3 Despite a national effort to control the epidemic of non-medical use of opioid analgesics and a plateauing of opioid analgesic-related ED visits 6 and mortality rates 7 in the early 2010s, the prevalence of heroin use rose dramatically during the same time period, with over 620,000 Americans reporting the use of heroin in 2011. 8 The recent addition of fentanyl to the supply of heroin and other street drugs has resulted in a further increase in the risk of opioid overdose death 9 , 10 observed across men and women and various racial/ethnic groups.…”

Section: Introductionmentioning

confidence: 99%

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment

Clemency

Hoopsick

Burnett

et al. 2022

WestJEM

View full text Add to dashboard Cite

Introduction: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death. Patients in crisis from opioid use disorder (OUD) often seek care from emergency departments (ED). The New York Medication for Addiction Treatment and Electronic Referrals (MATTERS) network is designed to support ED-initiated buprenorphine and urgent referrals to long-term care for patients suffering from OUD. Methods: Using the PRECEDE-PROCEED implementation science framework, we provide an overview of the creation of the MATTERS network in Western New York. We also include an explanation of how the network was designed and launched as a response to the opioid epidemic. Finally, we analyzed the program’s outputs and outcomes, thus far, as it continues to grow across the state. Results: The New York MATTERS network was created and implemented in 2019 with a single hospital referring patients with OUD to three local clinics. In the social assessment and situational analysis phase, we describe the opioid epidemic and available resources in the region at the outset of the program. In the epidemiological assessment phase, we quantify the epidemic on the state and regional levels. In the educational and ecological assessment, we review local ED practices and resources. In the administrative and policy assessment and intervention alignment phase, the program’s unique framework is reviewed. In the piloting phase, we describe the initial deployment of New York MATTERS. Finally, in the process evaluation phase, we depict the early lessons we learned. By the beginning of 2021, the New York MATTERS network included 35 hospitals that refer to 47 clinics throughout New York State. Conclusion: The New York MATTERS network provides a structured approach to reduce barriers to ED-initiated buprenorphine and urgent referral to long-term care. An implementation framework provides a structured means of evaluating this best practice model.

show abstract

Opioid-related Emergency Department Visits and Hospitalizations Among Commercially Insured Individuals, 2009-2015

Abstract: Rates of opioid-related EDVs and hospitalizations, as well as concurrent opioid and benzodiazepine use, vary geographically. More research is needed to examine factors that impact regional variation and what influences the concurrent use of opioids and benzodiazepines.

Cited by 8 publications

References 21 publications

Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital

Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital

Effects of Unemployment on Opioid Use Treatment Trajectories

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment

Contact Info

Product

Resources

About